Results 211 to 220 of about 1,117,895 (256)
Some of the next articles are maybe not open access.

Tumor Shrinkage and Objective Response Rates

The Cancer Journal, 2009
Phase II clinical trials have long been used to screen new cancer therapeutics for antitumor activity ("efficacy") worthy of further evaluation. Traditionally, the primary end point used in these screening trials has been objective response rate (RR), with the desired rate being arbitrarily set by the researchers before initiation of the trial.
Penelope, Bradbury, Lesley, Seymour
openaire   +2 more sources

I/O Response Rate Analysis in the Replicate-Based Object Storage System

2010 Ninth International Symposium on Distributed Computing and Applications to Business, Engineering and Science, 2010
With the development of storage technology, storage system capacity has been rapidly growing, so rapid that storage I/O performance has become one of the most critical issues in large complex systems. This article combines the latest research in object-based storage with replica technology to share I/O in the object storage system, and to maintain high
Zhipeng Tan   +4 more
openaire   +1 more source

Abstract 1041: Circulating tumor (ct)DNA molecular response rate (MRR) as a potential surrogate for radiologic objective response rate (ORR): A meta-analysis of immunotherapy studies

Cancer Research, 2023
Abstract Background: Previous studies have shown that ctDNA MR defined by 50% reduction of ctDNA levels after immune checkpoint inhibitor (ICI) treatment is significantly associated with improved survival. However, discordance between MR and radiologic response was observed, hindering the potential use of MR as a surrogate endpoint.
Qu Zhang   +6 more
openaire   +1 more source

Objective Response Rate As a Surrogate End Point: A Commentary

Journal of Clinical Oncology, 2005
Bruzzi et al have evaluated objective response rate (ORR) as a potential surrogate end point for survival in metastatic breast cancer patients. Throughout oncology, many biomarkers have been evaluated. Examples include direct measures of the tumor burden process, such as ORR or progression-free survival (PFS), or inherently less reliable indirect ...
openaire   +1 more source

Influence of pretreatment tumor growth rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization

Journal of Gastroenterology and Hepatology, 2019
AbstractBackground and AimThe study aims to assess the influence of pretreatment tumor growth rate (TGR) on modified response evaluation criteria in solid tumors (mRECIST) objective response (OR) after a first session of selective transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma (HCC).MethodsOne hundred fifteen ...
Yvonne Purcell   +4 more
openaire   +2 more sources

Abstract A21: Effect of forced-response on completion rate in objective Internet-based health survey

Cancer Epidemiology, Biomarkers & Prevention, 2020
Abstract Introduction: Forced-response in Internet-based surveys is one solution to item nonresponse in population science research, but forced-response can inflate dropout rate and introduce bias. As a result, forced-response has been described as a trade-off between data quantity and data quality.
Lenna Dawkins-Moultin   +2 more
openaire   +1 more source

An efficient multiple-stage procedure for phase II clinical trials that have high response rate objectives

Controlled Clinical Trials, 1994
Gehan's two-stage procedure is commonly used in phase II clinical trials to enable one to stop a trial early if the observed response rate in the first stage does not warrant further study and to obtain an adequate estimate of response rate if the trial passes the first stage. However, when the response rate of interest is relatively high (0.3 or more),
S, Chen, S J, Soong, R H, Wheeler
openaire   +2 more sources

Neoadjuvant immunochemotherapy in locally advanced laryngeal cancer and hypopharyngeal cancer: higher objective response rate and organ-preservation rate

Investigational New Drugs
This study retrospectively analyzed the curative effect of neoadjuvant PD-1 inhibitors combined with chemotherapy of locally advanced laryngeal and hypopharyngeal cancer and compared with chemotherapy plus EGFR inhibitors and chemotherapy alone. From January 1 2018 to October 1 2023, a total of 113 patients in Beijing Tongren Hospital, who were ...
Shaoshi, Chen   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy